Details of the Drug

General Information of Drug (ID: DMJLFAK)

• Drug Name: TAK-062
• Synonyms: zamaglutenase

Indication

Disease Entry	ICD 11	Status	REF
Coeliac disease	DA95	Phase 2	[1]

• Drug Type: Enzyme replacement
• Cross-matching ID: TTD ID: DBJ50D

References

• [1] ClinicalTrials.gov (NCT05353985) A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-062 for the Treatment of Active Celiac Disease in Subjects Attempting a Gluten-Free Diet. U.S.National Institutes of Health.